Amit B. Shah - 08 Jul 2021 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Amit Shah
Issuer symbol
OTLC
Transactions as of
08 Jul 2021
Net transactions value
$0
Form type
4
Filing time
16 Jul 2021, 17:37:37 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Award $0 +298,837 +498% $0.000000 358,837 08 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLC Stock Options Award $0 +698,256 $0.000000 698,256 08 Jul 2021 Common Stock 698,256 $0.1626 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued in settlement of Restricted Stock Units granted pursuant to the Issuer's 2015 Equity Incentive Plan that vested immediately upon grant.
F2 Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan, which vest immediately on date of grant.